STAT — Reporting from the frontiers of health and medicine

First Opinion Disruptive science is leaping forward, not limping along
Health Tech GoodRx leaked sensitive health information to Facebook and Google, FTC alleges
Biotech STAT Plus: 6 things to know about Apellis’ eye drug ahead of FDA decision
First Opinion Promises — and pitfalls — of ChatGPT-assisted medicine
Insurance STAT Plus: Medicare Advantage insurers will score $2 billion gift thanks to limited audits
Biotech STAT Plus: KKR veteran sets records with $3.9 billion health care fund
First Opinion Unlocking the promise of learning from everyone with cancer

STAT Plus: ‘Ill-gotten gains’: FTC commissioner says GoodRx’s $1.5 million fine for health data leaks should have been higher

By Brittany Trang

Health

MRI scans reveal disparate impact of poverty and other ‘toxic stress’ on brains of Black children

By Usha Lee McFarling

Health Tech

STAT Plus: New antidepressant study provides hints to Verily’s future

By Matthew Herper and Casey Ross

First Opinion Disruptive science is leaping forward, not limping along
Health Tech GoodRx leaked sensitive health information to Facebook and Google, FTC alleges
Biotech STAT Plus: 6 things to know about Apellis’ eye drug ahead of FDA decision
First Opinion Promises — and pitfalls — of ChatGPT-assisted medicine
Insurance STAT Plus: Medicare Advantage insurers will score $2 billion gift thanks to limited audits
Biotech STAT Plus: KKR veteran sets records with $3.9 billion health care fund
First Opinion Unlocking the promise of learning from everyone with cancer

Exclusive analysis of biotech, pharma, and the life sciences

Learn more

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Start your free trial!

STAT Plus: No more ‘playing God’: How the longevity field is trying to recast its work as serious science
STAT Plus: FDA names former Oracle executive as new digital health leader
STAT Plus: U.K. lawmakers urge Pfizer not to raise the price of its Covid-19 vaccine

A STAT Investigation

DEATH SENTENCE: An 8-part investigation into prisons’ refusal to treat hepatitis C

By Nicholas Florko

Special Report

STAT Plus: We finally have new drugs for sickle cell disease. Why are so few patients taking them?

By Jason Mast

Health

Revenge of the gaslit patients: Now, as scientists, they’re tackling Ehlers-Danlos syndromes

By Isabella Cueto

Biotech

STAT Plus: ‘We were right all along:’ For Japanese drugmaker Eisai, success against Alzheimer’s has been a long time coming

By Adam Feuerstein, Jason Mast and Damian Garde

Special Report

‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia

By Jonathan Wosen

Health

Every kick, a reminder: in post-Roe California, a painful wait before ending a wanted pregnancy

By Eric Boodman

Health

Before making unbiased pulse oximeters, researchers need a better way to measure skin tone

By Usha Lee McFarling

A STAT Investigation

STAT Plus: ‘Out of control’: Dozens of telehealth startups sent sensitive health information to big tech companies

By Katie Palmer — STAT and Todd Feathers and Simon Fondrie-Teitler — The Markup

Health Tech GoodRx leaked sensitive health information to Facebook and Google, FTC alleges
First Opinion Disruptive science is leaping forward, not limping along
Insurance STAT Plus: Medicare Advantage insurers to repay billions under final federal audit rule
Biotech STAT Plus: 6 things to know about Apellis’ eye drug ahead of FDA decision
Health MRI scans reveal disparate impact of poverty and other ‘toxic stress’ on brains of Black children
First Opinion Promises — and pitfalls — of ChatGPT-assisted medicine
Health Tech STAT Plus: Top Verily executives depart amid leadership shakeup and layoffs
Health Tech STAT Plus: ChatGPT in health care: 5 burning questions about the buzzy new tool
Politics STAT Plus: Medicare may test policy of paying less for accelerated approval drugs

All Popular Stories

An afternoon roundup of STAT’s top stories of the day

Please enter a valid email address.

The Readout LOUD

Listen: George Scangos’ retirement, annual Covid vaccines, an Alzheimer’s drug rejection

By Adam Feuerstein and Meg Tirrell

Pharma

STAT Plus: Watch: How do the new obesity drugs work?

By Alex Hogan and Mallory Brangan

The Readout LOUD

Listen: How blockbusters get made, new vaccines for RSV, and mRNA’s Q score

By Damian Garde, Meg Tirrell and Adam Feuerstein

The Readout LOUD

Listen: #JPM23, the future of Alzheimer’s, & rising Covid variants

By Damian Garde, Meg Tirrell and Adam Feuerstein

Reporter Spotlight

Ambar Castillo is a 2022-2023 Sharon Begley Science Reporting Fellow at STAT.

Ambar's Profile

Nicholas Florko reports on the commercial determinants of health.

Nicholas's Profile

Brittany Trang is a 2022-2023 Sharon Begley Science Reporting Fellow at STAT.

Brittany's Profile

View All

Ambar's LatestMore from Ambar

In the Lab

Mistakes happen in research papers. But corrections often don’t

By Ambar Castillo

Health

U.S. life expectancy falls for second straight year as drug overdose and Covid deaths take toll

By Ambar Castillo

Nicholas's LatestMore from Nicholas

Politics

STAT Plus: It’s easy to buy flavored vapes in California, even in cities with longtime bans

By Nicholas Florko

Politics

STAT Plus: After nearly 4 years of deliberation, FDA punts on how to regulate CBD

By Nicholas Florko

Brittany's LatestMore from Brittany

Health Tech

STAT Plus: ‘Ill-gotten gains’: FTC commissioner says GoodRx’s $1.5 million fine for health data leaks should have been higher

By Brittany Trang

Health Tech

STAT Plus: Alphabet’s laid-off health tech employees on where their work heads next

By Brittany Trang

STAT Plus: ‘Ill-gotten gains’: FTC commissioner says GoodRx’s $1.5 million fine for health data leaks should have been higher

MRI scans reveal disparate impact of poverty and other ‘toxic stress’ on brains of Black children

STAT Plus: New antidepressant study provides hints to Verily’s future

Exclusive analysis of biotech, pharma, and the life sciences

Start your free trial!

DEATH SENTENCE: An 8-part investigation into prisons’ refusal to treat hepatitis C

STAT Plus: We finally have new drugs for sickle cell disease. Why are so few patients taking them?

Revenge of the gaslit patients: Now, as scientists, they’re tackling Ehlers-Danlos syndromes

STAT Plus: ‘We were right all along:’ For Japanese drugmaker Eisai, success against Alzheimer’s has been a long time coming

‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia

Every kick, a reminder: in post-Roe California, a painful wait before ending a wanted pregnancy

Before making unbiased pulse oximeters, researchers need a better way to measure skin tone

STAT Plus: ‘Out of control’: Dozens of telehealth startups sent sensitive health information to big tech companies

Listen: George Scangos’ retirement, annual Covid vaccines, an Alzheimer’s drug rejection

STAT Plus: Watch: How do the new obesity drugs work?

Listen: How blockbusters get made, new vaccines for RSV, and mRNA’s Q score

Listen: #JPM23, the future of Alzheimer’s, & rising Covid variants

Reporter Spotlight

Ambar's LatestMore from Ambar

Mistakes happen in research papers. But corrections often don’t

U.S. life expectancy falls for second straight year as drug overdose and Covid deaths take toll

Nicholas's LatestMore from Nicholas

STAT Plus: It’s easy to buy flavored vapes in California, even in cities with longtime bans

STAT Plus: After nearly 4 years of deliberation, FDA punts on how to regulate CBD

Brittany's LatestMore from Brittany

STAT Plus: ‘Ill-gotten gains’: FTC commissioner says GoodRx’s $1.5 million fine for health data leaks should have been higher

STAT Plus: Alphabet’s laid-off health tech employees on where their work heads next

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day